Search

1337 publications found

Jun 21, 2004 Editorial
Libertà vo cercando

by Pietro Greco

Free information works. In the sense that Open Access Journals, scientific journals which can be accessed at no cost, thereby guaranteeing free access to everyone, are at the same time able to guarantee the same quality as –or even better than- that of traditional journals, which can only be read by those willing to pay a price, be it the cover price or a subscription.

Volume 3 • Issue 02 • 2004

Mar 21, 2004 Editorial
Science and the international public opinion

by Pietro Greco

On 16 January 2004, the United Nations Secretary-General and Nobel Peace Prize winner Kofi Annan launched a Global Media Aids Initiative, with the aim of convincing the press, radio, television and Internet to join the fight against what has been called the "forgotten disease of the forgotten continent". Throughout the world, over 40 million people have the Hiv virus. In 2003 there were 5 million new infections and 3 million deaths were caused by Aids.

Volume 3 • Issue 01 • 2004

Mar 21, 2004 Focus
The public way to peer-review

by Nico Pitrelli

There is a substantial divergence between the standards of integrity associated with "good science" and the problems imposed by the conflict of interest on research, specially in the biomedical field. There are at least as many ways in which information may be altered and the production of new scientific knowledge may be affected as there are links that can be established between researchers, private companies, and editors and staff of the specialized press. The pressures resulting from this high number of connections can affect all stages of research, from trial design to data analysis, from result publishing and dissemination to who will be the author of the articles.

Volume 3 • Issue 01 • 2004

Mar 21, 2004 Focus
Anything to declare? Border stories on the conflict of interest

by Giancarlo Sturloni

On September 15, 2001, a joint editorial simultaneously published in thirteen medical journals, pointed an accusing finger at the increasing pressures coming from the pharmaceutical industry. During past decades, a key role in trial design and conduct was played by independent clinical investigators working in academic medical centres. They were also able to vouchsafe the quality of their research, which might not, however, be the case in the future.

Volume 3 • Issue 01 • 2004

Search